PI3Kα inhibitors that inhibit metastasis.

Oncotarget

Volumn 1, Issue 5, 2010, Pages 339-348

  Schmidt Kittler, Oleg ^a   Zhu, Jiuxiang ^b   Yang, Jian ^b   Liu, Guosheng ^b   Hendricks, William ^b   Lengauer, Christoph ^b   Gabelli, Sandra B ^b   Kinzler, Kenneth W ^b   Vogelstein, Bert ^b   Huso, David L ^b   Zhou, Shibin ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR;

ANIMAL; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CELL STRAIN HCT116; CHEMISTRY; COLORECTAL TUMOR; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; LIVER TUMOR; LUNG TUMOR; METABOLISM; METASTASIS; MOLECULARLY TARGETED THERAPY; MOUSE; MUTATION; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TIME; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; FEMALE; HCT116 CELLS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, NUDE; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952087950     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.166     Document Type: Article

References (0)